Scientis Pharma, a leading dermatology research company based in Geneva, Switzerland, has released the world’s first cysteamine-based cream to treat hyperpigmentation disorders. Cysteamine Cream® is a novel, super potent skin...
Read MoreLEVEL 7 Injectable Therapies and LEVEL 5 Laser & light qualifications now available
Read MoreArtificial Intelligence used to erase scarring
Read MoreWendy Lewis unveils the new rules of three T’s: two-way conversations, transparency, and trust building
Read MoreFounded eight years ago by Dr. Joel Schlessinger, Cosmetic Surgery Forum is a multi-specialty, discussion-based course covering the latest in research, treatments and techniques in dermatology and cosmetic surgery. We (more…)
Read MoreHema Sundaram, MD, reviews IBSA’s latest breakthrough BDDE-free, thermally stable hyaluronic acid for skin remodelling
Read MoreAs we celebrate nearly 25 years since the cosmetic use of botulinum toxin was first described in the medical literature, the landscape of aesthetic medicine continues to evolve. One area of increasing (more…)
Read More